I forced a bot to read 1000 #internalmedicine personal statements & write its own. The syntax is a little off, but this bot has the template down! (Credit to @KeatonPatti's shtick.)
#meded#match2019
Disclosures: I read every PS in detail, and I love interviewing applicants.
Great day for oligometastatic disease! In a 24 hrs, 3 randomized trials demonstrate substantially improved survival in oligometastatic patients treated w/ consolidative RT. Lung: https://t.co/LxIEa1c8WX prostate: https://t.co/Qz5xl3kZVo all tumor types: https://t.co/KwjK1e7arh
Exciting data from our NRG colleagues. Sets the tone for S1806. Congrats on a very nice trial.
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Canc.. https://t.co/uzx2M1YFgB
Now in our Nov issue: previously presented at #ESMO2018@myESMO: #Nivolumab plus #ipilimumab or nivolumab alone versus ipilimumab alone in advanced #melanoma (#CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial https://t.co/5T8POrSXkg